Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics developer, has announced that it has signed an extension to its exclusive licensing and partnership agreement for the USA and Canada, executed
Cizzle Biotechnology plc (LON:CIZ) Executive Chairman Dr Allan Syms caught up with DirectorsTalk for an exclusive interview to discuss the unique advantages of the CIZ1B biomarker, BIO’s partnership strategy, the
Cizzle Biotechnology plc (LON:CIZ) Executive Chairman Dr Allan Syms joins DirectorsTalk Interviews to discuss an exclusive licensing and partnership agreement for its proprietary CIZ1B biomarker. In this interview, Cizzle Biotechnology’s Executive
Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics developer, has announced that it has today signed an exclusive licensing and partnership agreement for its proprietary CIZ1B biomarker test to help detect
Cizzle Biotechnology plc (LON:CIZ) Executive Chairman Dr Allan Syms joins DirectorsTalk Interviews to discuss a collaboration with Moffitt Cancer Center the number one cancer hospital in Florida and the Southeast USA.
Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics company focused on developing a cost-effective biomarker test to help detect early-stage lung cancer, has announced that it has been selected by
Cizzle Biotechnology Holdings plc (LON:CIZ), the UK-based diagnostics company focused on developing a cost effective biomarker test to help detect early-stage lung cancer, has announced a strategic agreement with BBI Solutions,
Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics developer, has announced the publication of the Company’s Annual Report and Financial Statements for the year ended 31 December 2023: Cizzle
Cizzle Biotechnology plc’s Executive Chairman discusses new Licensing and Partnership MoU for North America, focusing on revenue streams and market expansion.
Cizzle Biotechnology plc (LON:CIZ) Executive Chairman Dr Allan Syms joins DirectorsTalk Interviews to discuss a strategic and exclusive licensing agreement to develop and offer its proprietary test throughout the USA and
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
